Home > Insider Trading > Filing (0001209191-21-049823)

Filing Details

Accession Number:: 0001209191-21-049823
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-04 21:19:46
Reporting Period:: 2021-07-28

Accepted Time:: 2021-08-04 21:19:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1739410	Rallybio Corp	RLYB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1664281	Kush Parmar	C/O Rallybio Corporation 234 Church Street, Suite 1020 New Haven CT 06510		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-07-28	2,784,626	$0.00	2,784,626	No	4	J	Indirect	5AM Ventures V, L.P.
Common Stock	Acquisiton	2021-07-28	790,714	$0.00	790,714	No	4	J	Indirect	5AM Opportunities I, L.P.
Common Stock	Acquisiton	2021-08-02	615,384	$13.00	1,406,098	No	4	P	Indirect	5AM Opportunities I, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	5AM Ventures V, L.P.
No	4	J	Indirect	5AM Opportunities I, L.P.
No	4	P	Indirect	5AM Opportunities I, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred Units	Disposition	2021-07-28	1,795,946	$0.00	282,044	$0.00
Common Stock	Series A-2 Preferred Units	Disposition	2021-07-28	8,742,654	$0.00	1,372,990	$0.00
Common Stock	Series B Preferred Units	Disposition	2021-07-28	7,192,795	$0.00	1,129,592	$0.00
Common Stock	Series B Preferred Units	Disposition	2021-07-28	5,034,955	$0.00	790,714	$0.00
Common Stock	Option (Right to Buy)	Acquisiton	2021-07-28	13,440	$0.00	13,440	$13.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	No	4	J	Indirect
0	No	4	J	Indirect
0	No	4	J	Indirect
0	No	4	J	Indirect
13,440	No	4	A	Direct

Footnotes

The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred units (collectively, the "Preferred Units") reported herein were preferred units of Rallybio Holdings, LLC. The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the "Plan of Liquidation"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation.
These securities are held directly by 5AM Ventures V, L.P. ("Ventures V"). 5AM Partners V, LLC ("Partners V") is the sole general partner of Ventures V. Dr. Parmar is a managing member of Partners V and may be deemed to share voting and investment power over the securities held by Ventures V. Dr. Parmar disclaims beneficial ownership of the securities held by Ventures V except to the extent of his pecuniary interest therein.
These securities are held directly by 5AM Opportunities I, L.P. ("Opportunities I, L.P."). 5AM Opportunities I (GP), LLC ("Opportunities I (GP)") is the general partner of Opportunities I, L.P. Dr. Parmar is a managing member of Opportunities I (GP), and may be deemed to share voting and dispositive power over the securities held by Opportunities I, L.P. Dr. Parmar disclaims beneficial ownership of the securities held by Opportunities I, L.P. except to the extent of his pecuniary interest therein.
Prior to the effectiveness of the Plan of Liquidation, the Preferred Units were convertible into common units of Rallybio Holdings, LLC.
The option vests as to the underlying shares of Common Stock on the earlier of July 28, 2022 and the date of the first annual meeting of stockholders of the Issuer following the closing of its initial public offering.